Detection and Management of Pre-existing Cognitive Impairment and Associated Behavioral Symptoms in the Intensive Care Unit

Critical Care Clinics

Volumn 24, Issue 4, 2008, Pages 723-736

  Lee, Hochang B ^a   DeLoatch, Candyce J ^a   Cho, SeongJin ^a   Rosenberg, Paul ^a   Mears, Simon C ^a   Sieber, Frederick E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CITALOPRAM; DONEPEZIL; DULOXETINE; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; LORAZEPAM; MEMANTINE; METHYLPHENIDATE; MIDAZOLAM; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PSYCHOSTIMULANT AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VALPROIC ACID; VENLAFAXINE;

AGGRESSION; AGITATION; ALZHEIMER DISEASE; AMNESIA; ANTICHOLINERGIC EFFECT; APATHY; ASTHMA; BEHAVIOR DISORDER; BRADYCARDIA; CLINICAL FEATURE; COGNITIVE DEFECT; DELIRIUM; DELUSION; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; DYSTONIA; ELDERLY CARE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HUMAN; HYPERTENSION; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTENSIVE CARE UNIT; LOW DRUG DOSE; MAJOR DEPRESSION; METABOLIC SYNDROME X; MORBIDITY; MUSCLE CRAMP; NAUSEA; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PREVALENCE; PRIAPISM; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOSIS; PSYCHOTHERAPY; RECOMMENDED DRUG DOSE; RESTLESSNESS; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; STOMACH ACID SECRETION; STROKE; TRANSIENT ISCHEMIC ATTACK; VOMITING; WEIGHT GAIN;

AGED; ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; DELIRIUM; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; GERIATRICS; HUMANS; INTENSIVE CARE UNITS; MENTAL DISORDERS;

EID: 53249090160     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2008.05.006     Document Type: Review

References (52)

1. US Census Bureau. Current population reports, series P23-209, sixty-five plus in US: 2005. Available at:. www.census.gov Accessed March 6, 2008
2. Alzheimer's Association. Alzheimer's facts and figures, 2007. Available at:. www.alz.org Accessed March 6th, 2008
3. Chelluri L., Pinsky M.R., Donahoe M.P., et al. Long-term outcome of critically ill elderly patients requiring intensive care. JAMA 269 (1993) 3119-3123
4. Knaus W.A., Wagner D.P., Draper E.A., et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100 (1991) 1619-1636
5. Angus D.C., Kelley M.A., Schmitz R.J., et al. Caring for the critically ill patient: current and projected workforce requirements for care of the critically ill and patients with pulmonary disease; can we meet the requirements of an aging population?. JAMA 284 (2000) 2762-2770
6. Erkinjuntti T., Wikstrom J., Palo J., et al. Dementia among medical inpatients: evaluation of 2000 consecutive admissions. Arch Intern Med 146 (1986) 1923-1926
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition (1994), American Psychiatric Association, Washington, DC
8. Rabins P., Lyketsos C.G., and Steele C.D. Practical dementia care (1999), Oxford University Press, New York
9. Fox N., Warrington E., Seiffer A., et al. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease: a longitudinal prospective study. Brain 121 (1998) 1631-1639
10. Petersen R.C., Smith G.E., Waring S.C., et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 (1999) 303-308
11. Graham J.E., Rockwood K., Beattie B.L., et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349 (1997) 1793-1796
12. Tierney M.C., Szalai J.P., Snow W.G., et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 46 (1996) 661-665
13. Bowen J., Teri L., Kukull W., et al. Progression to dementia in patients with isolated memory loss. Lancet 349 (1997) 763-765
14. Pisani M.A., McNicoll L., Inouye S.K., et al. Cognitive impairment in the intensive care unit. Clin Chest Med 24 (2003) 727-737
15. Fields S.D., MacKenzie C.R., Charlson M.E., et al. Cognitive impairment: can it predict the course of hospitalized patients?. J Am Geriatr Soc 34 (1986) 579-585
16. Ely E.W., Margolin R., Francis J., et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 29 7 (2001) 1370-1379
17. McNicoll L., Pisani M.A., Zhang Y., et al. Delirium in the intensive care unit: occurrence and clinical course in older patients. J Am Geriatr Soc 51 5 (2003) 591-598
18. Pisani M.A., Murphy T.E., Van Ness P.H., et al. Characteristics associated with delirium in older patients in a medical intensive care unit. Arch Intern Med 167 15 (2007) 1629-1634
19. Inouye S.K. Delirium in older persons. N Engl J Med 354 11 (2006) 1157-1165
20. Milbrandt E.B., Deppen S., Harrison P.L., et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 32 4 (2004) 955-962
21. Ely E.W., Gautam S., Margolin R., et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 27 12 (2001) 1892-1900
22. Ely E.W., Shintani A., Truman B., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291 14 (2004) 1753-1762
23. Pompei P., Foreman M., Rudberg M.A., et al. Delirium in hospitalized older persons: outcomes and predictors. J Am Geriatr Soc 42 8 (1994) 809-815
24. O'Keeffe S.T., and Lavan J.N. Predicting delirium in elderly patients: development and validation of a risk-stratification model. Age Ageing 25 4 (1996) 317-321
25. Litaker D., Locala J., Franco K., et al. Preoperative risk factors for postoperative delirium. Gen Hosp Psychiatry 23 2 (2001) 84-89
26. Ljubisavljevic V., and Kelly B. Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 25 5 (2003) 345-352
27. Rothschild J.M., Leape L.L., and Smith A.H. The nature and extent of medical injury in older patients: executive summary (2000), AARP Public Policy Institute, Washington, DC
28. Roca R.P., Klein L.E., Kirby S.M., et al. Recognition of dementia among medical patients. Arch Intern Med 144 (1984) 73-75
29. Pisani M.A., Redlich C., McNicoll L., et al. Under-recognition of pre-existing cognitive impairment by physicians in older ICU patients. Chest 124 (2003) 2267-2274
30. Callahan C.M., Hendrie H.C., and Tierney W.M. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med 122 (1995) 422-429
31. Valcour V.G., Masaki K.H., Curb J.D., et al. The detection of dementia in the primary care setting. Arch Intern Med 160 (2000) 2964-2968
32. Ardern M., Mayou R., Feldman E., et al. Cognitive impairment in the elderly medically ill: how often is it missed. Int J Geriatr Psychiatry 8 (1993) 929-937
33. Bergeron N., Dubois M.J., Dumont M., et al. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 27 (2001) 859-864
34. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 3 (1975) 189-198
35. Blessed G., Tomlinson B.E., and Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114 (1968) 797-811
36. Jorm A.F., Scott R., Cullen J.S., et al. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med 21 (1991) 785-790
37. Pisani M.A., Inouye S.K., McNicoll L., et al. Screening for pre-existing cognitive impairment in older intensive care unit patients: use of proxy assessment. J Am Geriatr Soc 51 5 (2003) 689-693
38. Lyketsos C.G., Lopez O., Jones B., et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study. JAMA 288 (2002) 1475-1483
39. Steinberg M., Sheppard J.M., Tschanz J.T., et al. The incidence of mental and behavioral disturbances in dementia: the Cache County Study. J Neuropsychiatry Clin Neurosci 15 (2003) 340-345
40. Steinberg M., Tschanz J.T., Corcoran C., et al. The persistence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry 19 (2004) 19-26
41. Chan D.C., Kasper J.D., Black B.S., et al. Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: the Memory and Medical Care Study. Int J Geriatr Psychiatry 18 2 (2003) 174-182
42. Lyketsos C.G., and Olin J. Depression in Alzheimer's disease: overview and treatment. Biol Psychiatry 52 3 (2002) 243-252
43. Olin J.T., Katz I.R., Meyers B.S., et al. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. Am J Geriatr Psychiatry 10 2 (2002) 129-141
44. Lyketsos C.G., Steinberg M., Tschanz J.T., et al. Mental and behavioral disturbances in dementia: findings from the Cache County Study on memory in aging. Am J Psychiatry 157 (2000) 708-714
45. Weintraub D., and Hurtig H.I. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies. Am J Psychiatry 164 10 (2007) 1491-1498
46. Schneider L.S., Dagerman K.S., and Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294 (2005) 1934-1943
47. Jeste D.V., Blazer D., Casey D., et al. ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 33 5 (2008) 957-970
48. Miller L.J. The use of cognitive enhancers in behavioral disturbances of Alzheimer's disease. Consult Pharm. 22 (2007) 754-762
49. Profenno L.A., Jakimovich L., Holt C.J., et al. A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease. Curr Alzheimer Res 2 5 (2005) 553-558
50. Tariot P.N., Raman R., Jakimovich L., et al. Valproate Nursing Home Study Group. Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatry 13 11 (2005) 942-949
51. Tariot P.N., Erb R., Podgorski C.A., et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 155 1 (1998) 54-61
52. Parmalee P.A. Pain in cognitively impaired older persons. Clin Geriatr Med 12 3 (1996) 473-487